Discover how biosimilar immunotherapy is reshaping cancer care in India, making advanced treatments affordable, while highlighting the need for increased patient awareness and education. New Delhi: For many cancer patients in India, advanced treatments such as immunotherapy have long remained financially out of reach. The emergence of biosimilar immunotherapy drugs is now beginning.